![](/img/cover-not-exists.png)
Phase 2 study of lenvatinib (LN) in patients (Pts) with RET fusion-positive adenocarcinoma of the lung
Velcheti, V., Hida, T., Reckamp, K.L., Yang, J.C., Nokihara, H., Sachdev, P., Feit, K., Kubota, T., Nakada, T., Dutcus, C.E., Ren, M., Tamura, T.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw383.05
Date:
October, 2016
File:
PDF, 46 KB
english, 2016